ACHILLES THERAPEUTICS PL-ADR (ACHL) Stock Analyst Earnings Estimates
NASDAQ:ACHL - Nasdaq - US00449L1026 - ADR - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||||
| EBITDA YoY % growth | -6.73M | -13.48M -100.30% | -32.96M -144.51% | -60.91M -84.80% | -74.19M -21.80% | -70.542M 4.92% | N/A -2.21% | N/A -38.96% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -6.9M | -13.78M -99.71% | -33.73M -144.78% | -64.2M -90.34% | -77.88M -21.31% | -75.255M 3.37% | N/A -2.83% | N/A -36.98% | N/A 49.73% | N/A -20.00% | N/A -20.00% | N/A -143.22% | N/A -7.65% | N/A 22.34% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -9.62 | -1.82 81.08% | -1.74 4.40% | N/A 89.45% | N/A 33.33% | N/A -2,183.33% | N/A 47.81% | N/A -17.48% | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.37 20.17% | -0.32 -5.40% | -0.24 40.29% | -0.17 63.88% | -0.16 55.56% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | -24.072M -62.64% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -24.072M -23.36% | -13.77M 3.70% | -10.71M 39.83% | -7.65M 62.53% | -7.14M 70.34% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.48 -14.29% | -0.42 | -0.06 | -14.78% |
| Q2 2024 Q2Q % growth | -0.41 2.38% | -0.42 | 0.01 | 1.96% |
| Q1 2024 Q2Q % growth | -0.30 31.82% | -0.47 | 0.17 | 36.52% |
| Q4 2023 Q2Q % growth | -0.46 24.59% | -0.15 | -0.31 | -211.02% |
| Q3 2023 Q2Q % growth | -0.42 -31.25% | -0.41 | -0.01 | -2.94% |
| Q2 2023 Q2Q % growth | -0.42 4.55% | -0.43 | 0.01 | 1.18% |
| Q1 2023 Q2Q % growth | -0.44 2.22% | -0.41 | -0.03 | -7.17% |
| Q4 2022 Q2Q % growth | -0.61 -35.56% | -0.42 | -0.19 | -45.86% |
| Q3 2022 Q2Q % growth | -0.32 5.88% | -0.56 | 0.24 | 42.44% |
| Q2 2022 Q2Q % growth | -0.44 2.22% | -0.57 | 0.13 | 22.69% |
| Q1 2022 Q2Q % growth | -0.45 94.63% | -0.52 | 0.07 | 12.64% |
| Q4 2021 Q2Q % growth | -0.45 | -0.41 | -0.04 | -8.66% |
| Q3 2021 Q2Q % growth | -0.34 | -0.49 | 0.15 | 30.84% |
| Q2 2021 Q2Q % growth | -0.45 | -0.50 | 0.05 | 10.69% |
| Q1 2021 Q2Q % growth | -8.38 | -3.32 | -5.07 | -152.79% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 5.26% | 20.88% | 88.54% | 88.54% |
| Revenue | N/A | N/A | N/A | N/A |